Publications by authors named "H Lata"

The psychedelic mushroom market has expanded rapidly due to changing regulations and increasing consumer demand. Product diversity now extends beyond traditional capsules and tablets to include gummies, powders, and confectionery items, complicating quality control efforts. To assess the quality and potential adulteration of Amanita musca-ria and Psilocybe cubensis-based products, a validated LC-QToF-MS method was developed.

View Article and Find Full Text PDF
Article Synopsis
  • - High-quality red and dry chili breeding focuses on female sterile lines to utilize heterosis for improving yield and traits, including resilience to high rainfall.
  • - Forty F hybrids were developed from a mix of genetic male sterile (GMS) lines and testers, which were analyzed for their genetic combining ability and performance, emphasizing traits beneficial for commercial use.
  • - Ten promising hybrid combinations were identified, showing superior fruit yield and desirable traits, indicating the potential for these hybrids to be commercially adopted and tested in multiple locations for further exploitation.
View Article and Find Full Text PDF
Article Synopsis
  • * The WHO published the first COVID-19 Weekly Epidemiological Update on August 17, 2020, and continued until the final edition on September 1, 2023, after which updates transitioned to a comprehensive format every 4 weeks.
  • * The article reviews the WEU's data collection and publication process, its global impact, and offers recommendations to improve collaboration and information sharing for future health crises.
View Article and Find Full Text PDF
Article Synopsis
  • WHO collaborates with countries to manage acute public health events by providing reliable information through Disease Outbreak News (DON) reports.
  • Since 1996, WHO has published over 3000 DON reports, focusing on major health threats like Ebola and cholera, with significant public interest highlighted by 2.6 million visits per year.
  • The structure of DON reports has evolved to enhance clarity and detail, reflecting WHO's ongoing efforts to improve how they communicate health information globally.
View Article and Find Full Text PDF

Allergic sensitization to cannabis is an emerging public health concern and is difficult to clinically establish owing to lack of standardized diagnostic approaches. Attempts to develop diagnostic tools were largely hampered by the Schedule I restrictions on cannabis, which limited accessibility for research. Recently, however, hemp was removed from the classified list, and increased accessibility to hemp allows for the evaluation of its practical clinical value for allergy diagnosis.

View Article and Find Full Text PDF